Speaker illustration

Doctor Thomas Steen Gyldenstierne Sehested

Herlev and Gentofte Hospital, Copenhagen (Denmark)

Risk of upper gastrointestinal bleeding following myocardial infarction: a novel prediction model for assessing appropriateness of proton pump inhibition therapy

Event: ESC CONGRESS 2019

Topic: Pharmacotherapy

Session: New applications of risk assessment in coronary artery disease


Continuing decline in incidence of recurrent myocardial infarction, stroke, and death following first myocardial infarction: a 15-year nationwide cohort study

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Management of coronary disease: temporal trends and residual risk


Cost-effectiveness of canakinumab to prevent recurrent cardiovascular events

Event: ESC Congress 2018

Topic: Health Economics

Session: Health economics


Dose-response relationship between proton pump inhibitor use and associated risk of myocardial infarction: a nationwide cohort study

Event: ESC CONGRESS 2016

Topic: Drug therapy

Session: Lipid-lowering agents - New perspectives


This platform is supported by

logo Novo Nordisk